---
title: "INFOTMIC: Net loss of 13.0439 million yuan in the first quarter of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/238062142.md"
description: "INFOTMIC announced that its operating revenue in the first quarter of 2025 was 751 million yuan, a year-on-year decrease of 22.60%. The net loss was 13.0439 million yuan, compared to a net loss of 3.2763 million yuan in the same period last year"
datetime: "2025-04-29T12:50:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/238062142.md)
  - [en](https://longbridge.com/en/news/238062142.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/238062142.md)
generator: "portal-rs"
---

# INFOTMIC: Net loss of 13.0439 million yuan in the first quarter of 2025

INFOTMIC announced that its operating revenue in the first quarter of 2025 was 751 million yuan, a year-on-year decrease of 22.60%. The net loss was 13.0439 million yuan, compared to a net loss of 3.2763 million yuan in the same period last year

### Related Stocks

- [000670.CN](https://longbridge.com/en/quote/000670.CN.md)

## Related News & Research

- [Lens Technology Half-Year Profit Halves as Revenue Slides, Dividend Maintained](https://longbridge.com/en/news/296653059.md)
- [Fibocom sells Shanghai Faiot industrial handheld unit to Luxshare for RMB 120 million](https://longbridge.com/en/news/296613884.md)
- [REG - UIL Limited UIL Finance Ltd - Purchase of 2026 ZDP Shares](https://longbridge.com/en/news/296518280.md)
- [Reconova Technologies publishes shareholder letter on electronic corporate communications arrangements (FY2026)](https://longbridge.com/en/news/296596050.md)
- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**